Celiac Disease Trends in Top 6 Markets Reviewed & Forecast in New GlobalData Report Published at MarketPublishers.com24 Nov 2014 • by Natalie Aster
LONDON – Celiac disease is an autoimmune disorder that arises in people who consume gluten-containing food products but are intolerant to gluten, a protein found in some grains, like rye, wheat, and barley. Celiac disease can occur in individuals of all ages; the disease affects nearly 1% of the population in western nations, ranging between 0.3-2.7%.
The total prevalent cases of celiac disease in the 6 leading country markets will likely increase to 8.08 million cases by 2023-end at a rate of just over 3.9% per annum over the forecast period. The number of diagnosed prevalent cases in these markets is projected to grow by just over 4.6% over the next ten years to 1.11 million cases by the end of 2023.
New report “EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023” worked out by GlobalData presents an in-depth, top-quality, transparent and expert analysis of celiac disease trends in the 6 major markets.
The report presents a granular overview of the co-morbidities and risk factors, as well as historical and current trends for celiac disease in the 6 leading markets – the US, Germany, France, Spain, Italy, and the UK. The study canvasses the growth trends in the celiac disease market, reviews the patient population characteristic of celiac disease, limelights the existing treatment options, and also identifies the emerging market opportunities. Moreover, the research publication includes a detailed epidemiological forecast to 2023 for the overall prevalent cases of celiac disease by age and sex, as well as a long-term extensive epidemiological forecast for the diagnosed prevalent cases of celiac disease in the top 6 markets.
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023
Published: November, 2014
Price: US$ 3,995.00
Other Epidemiology Forecast Reports by GlobalData:
- EpiCast Report: Dyslipidemia - Epidemiology Forecast to 2023
- EpiCast Report: Asthma - Epidemiology Forecast to 2023
- EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023
- EpiCast Report: Breast Cancer (HER2-, HER2+) - Epidemiology Forecast to 2023
- EpiCast Report: Age-Related Macular Degeneration - Epidemiology Forecast to 2023
- EpiCast Report: Diabetic Macular Edema - Epidemiology Forecast to 2023
More new studies by the publisher can be found at GlobalData page.